SCAD's Genetic Mystery: Why Heart Attacks Strike Young Women

What They Found

Swedish researchers sequenced the genomes of 201 patients with spontaneous coronary artery dissection (SCAD) to map the genetic architecture of this mysterious condition. SCAD causes heart attacks in young, otherwise healthy women by creating tears in coronary artery walls without any plaque buildup or traditional risk factors.

Why It Matters

This is the largest genetic analysis of SCAD to date, targeting a condition that represents a completely different mechanism of coronary events than what we typically see. Unlike atherosclerotic heart attacks that build up over decades through inflammation and plaque formation, SCAD strikes suddenly through arterial wall failure — think structural engineering failure rather than plumbing blockage.

The genetic focus makes sense because SCAD clusters in families and disproportionately affects young women (80-90% of cases), often during pregnancy or postpartum when hormonal changes peak. Previous smaller studies identified variants in collagen genes like COL3A1 and fibrillin-1 (FBN1), suggesting connective tissue disorders drive the pathology. But the complete genetic picture remained unclear.

With 201 patients, this study has the power to identify both rare high-penetrance variants and more common genetic contributors. The comprehensive exome approach means they're not just looking at known suspects but scanning all protein-coding genes for novel associations.

What I'd Watch For

The abstract cuts off at "201 p" so we don't have the actual findings yet, but several limitations will likely emerge. First, population homogeneity — Swedish genetics may not translate globally, especially given known ethnic differences in connective tissue disorders. Second, the control group selection will be critical since many genetic variants associated with connective tissue are relatively common but only pathogenic under specific conditions.

The real test will be functional validation of any novel variants they identify. Finding a gene variant is one thing; proving it actually weakens arterial walls is another entirely.

Bottom Line

SCAD represents a fundamentally different cardiovascular risk model than what most longevity protocols address. If this study identifies actionable genetic markers, it could enable screening of high-risk individuals before their first — often fatal — event. I wouldn't change protocols based on a preprint abstract, but definitive genetic markers for SCAD would warrant inclusion in comprehensive genetic screening panels.